Director/PDMR Shareholding

RNS Number : 5331F

Port Erin Biopharma Investments Ltd

18 June 2012

 



Port Erin Biopharma Investments Limited

 ("Port Erin" or the "Company")

Director's Dealing

Port Erin, the AIM listed company focused on investing in the biotechnology and biopharmaceutical sectors, was informed that Galloway Limited purchased 500,000 Ordinary Shares at a price of 7 pence per share on 15 June 2012.

Galloway Limited is wholly owned by a trust in which Jim Mellon, Chairman of the Company, has a life tenancy. Denham Eke, a Director of the Company, is a director of Galloway Limited.

Following this transaction, the total Ordinary Shares in which Jim Mellon has a beneficial interest is 3,941,000, representing 11.8% of the issued ordinary share capital of the Company.

Enquiries:

Port Erin Biopharma Investments Limited
Denham Eke	([phone]
Libertas Capital Corporate Finance Limited
Sandy Jamieson	([phone]
Rivington Street Corporate Finance Limited
John Levinson	([phone]

 

END

 

 

RDSKDLBFLQFLBBV